|
|
|
Insider
Information: |
Lyons Gary A |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
506,803 |
|
Indirect Shares
|
387,931 |
|
|
Direct
Value |
$15,790,436 |
|
|
Indirect Value
|
$44,468,750 |
|
|
Total
Shares |
894,734 |
|
|
Total
Value |
$60,259,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-08-13 |
119,047 |
2005-12-19 |
383,573 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2003-11-25 |
0 |
2003-11-25 |
0 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Director |
2020-12-31 |
18,762 |
2009-05-21 |
0 |
Premium* |
|
Poniard Pharmaceuticals |
PARD |
Director |
2011-07-11 |
206,145 |
2010-07-12 |
0 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
36,849 |
2016-06-15 |
4,358 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
|
2024-05-08 |
51,000 |
2014-10-08 |
0 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
75,000 |
2021-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
118 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Director |
|
2019-11-08 |
4 |
AS |
$110.00 |
$550,000 |
D/D |
(5,000) |
225,697 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2021-10-07 |
4 |
AS |
$105.06 |
$525,294 |
D/D |
(5,000) |
208,697 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2022-10-04 |
4 |
AS |
$110.54 |
$552,711 |
D/D |
(5,000) |
203,697 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-09-01 |
4 |
AS |
$110.06 |
$550,316 |
D/D |
(5,000) |
203,697 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-09-01 |
4 |
OE |
$12.98 |
$64,900 |
D/D |
5,000 |
208,697 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-09-12 |
4 |
AS |
$115.02 |
$575,120 |
D/D |
(5,000) |
203,697 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-09-12 |
4 |
OE |
$12.98 |
$64,900 |
D/D |
5,000 |
208,697 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-12-01 |
4 |
AS |
$116.77 |
$583,837 |
D/D |
(5,000) |
203,697 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2023-12-01 |
4 |
OE |
$12.98 |
$64,900 |
D/D |
5,000 |
208,697 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2005-02-14 |
4 |
A |
$42.78 |
$241,493 |
D/D |
5,645 |
632,368 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
officerTitle |
|
2005-12-19 |
4 |
A |
$61.39 |
$346,669 |
I/I |
5,647 |
383,573 |
|
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2013-05-23 |
4 |
B |
$0.01 |
$60 |
D/D |
5,953 |
63,281 |
2.31 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2020-12-31 |
4 |
D |
$0.78 |
$4,654 |
D/D |
(5,967) |
18,762 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-12-08 |
4 |
A |
$45.87 |
$298,155 |
I/I |
6,500 |
626,723 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2004-12-08 |
4 |
D |
$45.87 |
$298,155 |
D/D |
(6,500) |
620,223 |
|
- |
|
TVTX |
Travere Therapeutics, Inc |
|
|
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
51,000 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2016-06-03 |
4 |
B |
$4.39 |
$31,089 |
D/D |
7,078 |
14,906 |
2.39 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2016-12-05 |
4 |
S |
$2.30 |
$16,248 |
D/D |
(7,078) |
7,828 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2012-05-24 |
4 |
B |
$0.01 |
$73 |
D/D |
7,328 |
57,328 |
2.31 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2014-05-22 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
70,781 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2015-01-20 |
4 |
OE |
$4.76 |
$35,700 |
D/D |
7,500 |
291,664 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2015-02-10 |
4 |
OE |
$4.76 |
$35,700 |
D/D |
7,500 |
298,062 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2015-05-21 |
4 |
A |
$0.01 |
$75 |
D/D |
7,500 |
78,281 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Director |
|
2020-08-31 |
4 |
D |
$0.94 |
$8,438 |
D/D |
(8,977) |
12,795 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
President and CEO |
|
2003-12-11 |
4 |
S |
$54.90 |
$549,811 |
D/D |
(10,000) |
682,013 |
|
- |
|
118 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|